Nicolette Stogios earned her PhD from the Institute of Medical Science at the University of Toronto in 2023. Her research focuses on the intricate relationship between antipsychotic medications, cardiometabolic risk, and cognitive function in individuals with severe mental illness. She aims to leverage this expertise to develop innovative treatment strategies that mitigate cognitive and metabolic impairments, ultimately enhancing the quality of life for those affected by these conditions.